lomustine has been researched along with Cat Diseases in 14 studies
Cat Diseases: Diseases of the domestic cat (Felis catus or F. domesticus). This term does not include diseases of the so-called big cats such as CHEETAHS; LIONS; tigers, cougars, panthers, leopards, and other Felidae for which the heading CARNIVORA is used.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to assess the efficacy and tolerability of lomustine, methotrexate and cytarabine chemotherapy as rescue treatment for feline lymphoma." | 8.02 | Lomustine, methotrexate and cytarabine chemotherapy as a rescue treatment for feline lymphoma. ( Blackwood, L; Harper, A; Smallwood, K, 2021) |
| "This retrospective study evaluated the use of lomustine as a rescue agent for 39 cases of resistant feline lymphoma." | 7.78 | Evaluation of lomustine as a rescue agent for cats with resistant lymphoma. ( Bulman-Fleming, JC; Dutelle, AL; Lewis, CA; Rosenberg, MP, 2012) |
| "The aim of this study was to assess the efficacy and tolerability of lomustine, methotrexate and cytarabine chemotherapy as rescue treatment for feline lymphoma." | 4.02 | Lomustine, methotrexate and cytarabine chemotherapy as a rescue treatment for feline lymphoma. ( Blackwood, L; Harper, A; Smallwood, K, 2021) |
| " Lymphoma was the most common cancer diagnosis; lomustine and vinca alkaloids were the most frequently implicated causative agents." | 3.85 | Febrile neutropenia in cats treated with chemotherapy. ( Barber, L; Boudreaux, B; DeRegis, C; Flory, A; Krick, E; Pierro, J; Regan, R; Saam, D; Saba, C, 2017) |
| "This retrospective study evaluated the use of lomustine as a rescue agent for 39 cases of resistant feline lymphoma." | 3.78 | Evaluation of lomustine as a rescue agent for cats with resistant lymphoma. ( Bulman-Fleming, JC; Dutelle, AL; Lewis, CA; Rosenberg, MP, 2012) |
| "Several anticancer drugs have been added to the therapeutic armamentarium in recent years." | 2.42 | New chemotherapy agents in veterinary medicine. ( Kitchell, BE; Moore, AS, 2003) |
| " No association between dosing frequency, cumulative dose, initial starting dose or concurrent medications, and increases in ALT were found." | 1.38 | Low apparent risk of CCNU (lomustine)-associated clinical hepatotoxicity in cats. ( Chretin, JD; Musser, ML; Quinn, HT, 2012) |
| "Necropsy identified severe diffuse pulmonary fibrosis and no signs of lymphoma." | 1.35 | Pulmonary fibrosis after high cumulative dose nitrosourea chemotherapy in a cat. ( Duda, L; Durham, AC; Skorupski, KA; Sørenmo, KU, 2008) |
| "This is the first case of histiocytic sarcoma in a cat to be reported in Japan." | 1.35 | Disseminated histiocytic sarcoma with excessive hemophagocytosis in a cat. ( Fujino, Y; Ide, K; Nakagawa, T; Nakayama, H; Ohno, K; Setoguchi-Mukai, A; Tsujimoto, H; Uetsuka, K, 2009) |
| "38 cats with measurable, histologically or cytologically confirmed MCTs treated with lomustine at a dosage > or = 50 mg/m(2)." | 1.35 | Lomustine for treatment of mast cell tumors in cats: 38 cases (1999-2005). ( Al-Sarraf, R; Baez, JL; Dank, G; Kristal, O; Rassnick, KM; Williams, LE; Zwahlen, CH, 2008) |
| " Complete remission was obtained after the third dosing regimen." | 1.33 | Diagnosis and treatment of a feline oral mast cell tumor. ( Chretin, JD; Wright, ZM, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Gieger, TL | 1 |
| Seiler, GS | 1 |
| Nolan, MW | 1 |
| Smallwood, K | 1 |
| Harper, A | 1 |
| Blackwood, L | 1 |
| Shih, JL | 1 |
| Brenn, S | 1 |
| Schrope, DP | 1 |
| Pierro, J | 1 |
| Krick, E | 1 |
| Flory, A | 1 |
| Regan, R | 1 |
| DeRegis, C | 1 |
| Boudreaux, B | 1 |
| Barber, L | 1 |
| Saam, D | 1 |
| Saba, C | 1 |
| Rau, SE | 1 |
| Burgess, KE | 1 |
| Skorupski, KA | 1 |
| Durham, AC | 1 |
| Duda, L | 1 |
| Sørenmo, KU | 1 |
| Ide, K | 1 |
| Setoguchi-Mukai, A | 1 |
| Nakagawa, T | 1 |
| Uetsuka, K | 1 |
| Nakayama, H | 1 |
| Fujino, Y | 1 |
| Ohno, K | 1 |
| Tsujimoto, H | 1 |
| Saba, CF | 1 |
| Vail, DM | 1 |
| Thamm, DH | 1 |
| Dutelle, AL | 1 |
| Bulman-Fleming, JC | 1 |
| Lewis, CA | 1 |
| Rosenberg, MP | 1 |
| Musser, ML | 1 |
| Quinn, HT | 1 |
| Chretin, JD | 2 |
| Moore, AS | 1 |
| Kitchell, BE | 1 |
| Komori, S | 1 |
| Nakamura, S | 1 |
| Takahashi, K | 1 |
| Tagawa, M | 1 |
| Wright, ZM | 1 |
| Rassnick, KM | 1 |
| Williams, LE | 1 |
| Kristal, O | 1 |
| Al-Sarraf, R | 1 |
| Baez, JL | 1 |
| Zwahlen, CH | 1 |
| Dank, G | 1 |
1 review available for lomustine and Cat Diseases
| Article | Year |
|---|---|
New chemotherapy agents in veterinary medicine.
Topics: Animals; Antineoplastic Agents; Cat Diseases; Cats; Deoxycytidine; Dog Diseases; Dogs; Gemcitabine; | 2003 |
1 trial available for lomustine and Cat Diseases
| Article | Year |
|---|---|
Phase II clinical evaluation of lomustine chemotherapy for feline vaccine-associated sarcoma.
Topics: Animals; Antineoplastic Agents; Cat Diseases; Cats; Dose-Response Relationship, Drug; Female; Lomust | 2012 |
12 other studies available for lomustine and Cat Diseases
| Article | Year |
|---|---|
Treatment of feline gastrointestinal intermediate- or large-cell lymphoma with lomustine chemotherapy and 8 Gy abdominal cavity radiation therapy.
Topics: Abdominal Cavity; Animals; Antineoplastic Combined Chemotherapy Protocols; Cat Diseases; Cats; Gastr | 2021 |
Lomustine, methotrexate and cytarabine chemotherapy as a rescue treatment for feline lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cat Diseases; Cats; Cyclophosphamide; Cytar | 2021 |
Cardiac involvement secondary to mediastinal lymphoma in a cat: regression with chemotherapy.
Topics: Animals; Anticonvulsants; Antineoplastic Agents; Asparaginase; Cat Diseases; Cats; Drug Therapy, Com | 2014 |
Febrile neutropenia in cats treated with chemotherapy.
Topics: Animals; Antineoplastic Agents; Cat Diseases; Cats; Febrile Neutropenia; Female; Leukocyte Count; Lo | 2017 |
A retrospective evaluation of lomustine (CeeNU) in 32 treatment naïve cats with intermediate to large cell gastrointestinal lymphoma (2006-2013).
Topics: Animals; Antineoplastic Agents, Alkylating; Cat Diseases; Cats; Female; Gastrointestinal Neoplasms; | 2017 |
Pulmonary fibrosis after high cumulative dose nitrosourea chemotherapy in a cat.
Topics: Adrenal Cortex Hormones; Animals; Antineoplastic Agents, Alkylating; Cat Diseases; Cats; Fatal Outco | 2008 |
Disseminated histiocytic sarcoma with excessive hemophagocytosis in a cat.
Topics: Animals; Antineoplastic Agents, Alkylating; Cat Diseases; Cats; Fatal Outcome; Female; Histiocytic S | 2009 |
Evaluation of lomustine as a rescue agent for cats with resistant lymphoma.
Topics: Animals; Antineoplastic Agents, Alkylating; Cat Diseases; Cats; Drug Resistance, Neoplasm; Female; L | 2012 |
Low apparent risk of CCNU (lomustine)-associated clinical hepatotoxicity in cats.
Topics: Alanine Transaminase; Animals; Antineoplastic Agents, Alkylating; Cat Diseases; Cats; Chemical and D | 2012 |
Use of lomustine to treat cutaneous nonepitheliotropic lymphoma in a cat.
Topics: Animals; Antineoplastic Agents, Alkylating; Cat Diseases; Cats; Fatal Outcome; Female; Lomustine; Ly | 2005 |
Diagnosis and treatment of a feline oral mast cell tumor.
Topics: Animals; Antineoplastic Agents, Alkylating; Cat Diseases; Cats; Lomustine; Male; Mast-Cell Sarcoma; | 2006 |
Lomustine for treatment of mast cell tumors in cats: 38 cases (1999-2005).
Topics: Animals; Antineoplastic Agents, Alkylating; Cat Diseases; Cats; Female; Kaplan-Meier Estimate; Lomus | 2008 |